OBJECTIVE:To probe into the compliance with the relevant requirements in the Guidelines for the Prevention and Treatment of Type 2 Diabetes in China（2017 Edition） for the use of stains in patients with type 2 diabetes mellitus（T2 DM） in endocrinology department in a grade Ⅲ

level A hospital（hereinafter referred to as " the hospital"）.METHODS:Retrospective investigation was conducted on patients with T2 DM from endocrinology department of the hospital in 2018.The hospital electronic medical record system was used to collect relevant examination results of patients and the use of statins in regulating blood lipids

the compliance rate between the use of statins and the requirements of guideline was analyzed.RESULTS:A total of 1 168 patients T2 DM discharged from the endocrinology department of the hospital were enrolled

of which 1 033 patients（88.44%） did not have arteriosclerotic cardiovascular disease（ASCVD）

and 135 patients（11.56%） complicated with ASCVD.The use of statins in 998 patients met the relevant requirements in the guidelines

and the compliance rate was 85.45%.There were 868 patients did not have ASCVD [84.03%（868/1033） in accordance with the guidelines]

and 130 patients complicated with ASCVD [96.30%（130/135） in accordance with the guidelines].CONCLUSIONS:Medical staff in the department of endocrinology of this hospital have a strong awareness of prevention and treatment of cardiovascular and cerebrovascular diseases in patients with T2 DM

and can actively follow the guidelines to recommend the use of statins to regulate blood lipids.